We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Urine Dipstick Accurately Predicts Renal Failure

By LabMedica International staff writers
Posted on 31 May 2012
Print article
The presence of excess protein in a common urine test is an effective prognostic marker of acute renal failure in patients with severe sepsis.

A urine dipstick test is routinely done as part of a urinalysis to help diagnose urinary tract infections, kidney disease, diabetes, and sepsis, the deadly bloodstream infection.

At the Henry Ford Hospital (Detroit, MI, USA) scientists analyzed data from 328 sepsis patients with no previous history of protein in the urine. After a urine sample was taken, a specially treated chemical strip was placed into the sample. The presence of such things as white blood cells, protein, or glucose in the urine is indicated by patches on the dipstick, which change color.

Many studies have shown the dipstick test to be a rapid detector for identifying urinary tract infections. However, this the first time the dipstick test has been evaluated for its accuracy of identifying renal failure in sepsis patients. They found the urine dipstick test predicted the presence of renal failure in 55% of these patients.

Javier Neyra, MD, a third-year resident at Henry Ford and the study's lead author, said, "The dipstick test excess protein, or proteinuria, resulted in fewer false positives and a greater threshold for detecting more severe renal failure compared to other biomarkers. Ultimately, the test may provide timely and early diagnosis of renal failure before substantial damage has already been done. This is a useful test that is widely available and inexpensive." The results of the study were presented at the National Kidney Foundation's annual meeting May 9-13, 2012, held in Washington DC, USA).

Related Links:
Henry Ford Hospital




Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Automated Blood Typing System
IH-500 NEXT
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA
New
Newborn Screening Test
NeoMass AAAC 3.0

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.